Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Aminoglycosides Market Set To Climb From $2.02 Billion In 2026 To $2.55 Billion By 2030
The market for aminoglycosides has experienced strong growth in recent years. Its value is forecast to expand from $1.91 billion in 2025 to $2.02 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.8%. This historical expansion can be attributed to factors such as a high incidence of abdominal and urinary tract infections, the widespread use of broad-spectrum antibiotics, conventional manufacturing processes, limited regulatory oversight in veterinary applications, and robust demand in ophthalmic solutions.
The aminoglycosides market size is projected to experience robust expansion over the coming years. This market is predicted to reach $2.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0%. This anticipated growth during the forecast period stems from factors such as heightened R&D efforts in targeted aminoglycoside treatments, growing recognition of antibiotic resistance, the implementation of sophisticated drug delivery methods, the enlarging veterinary healthcare sector, and the rise in personalized medicine applications. Key developments expected in the forecast period encompass an increasing incidence of gram-negative infections, greater application of aminoglycosides in veterinary contexts, the creation of new aminoglycoside derivatives, a move towards injectable and targeted formulations, and the widening scope of ophthalmic and inhalation uses.
Get A Free Sample Report With In-Depth Market Insights:
Aminoglycosides Market Growth Factors Behind Sustained Expansion
A significant factor projected to fuel the expansion of the aminoglycosides market is the increasing occurrence of animal disease outbreaks. An animal disease is defined as a disruption to an animal’s normal condition that interferes with or alters its vital processes. Aminoglycosides, including amikacin and gentamicin, find widespread application in veterinary medicine. For example, GOV.UK, a government agency based in the UK, indicated in July 2025 that laboratory-confirmed leptospirosis cases in England grew from 70 in 2023 to 102 in 2024, an increase of 45.7%. Additionally, 890 cases of pasteurellosis were recorded in 2024, up from 815 in 2023. Consequently, the growing frequency of animal disease outbreaks will consistently propel the aminoglycosides market. The projected expansion of the aminoglycosides market is further driven by a rise in pet ownership. Pet ownership involves the practice of housing and looking after animals, commonly known as pets, within one’s residence. A surge in pet ownership boosts the aminoglycoside market by expanding the consumer base, promoting a focus on proactive pet healthcare, and stimulating investment in veterinary pharmaceuticals to meet the varied health requirements of companion animals. For instance, as of March 2023, Improve International, a US-based veterinary educational resource, reported that 38 million pets reside in 16.2 million UK households, equating to approximately 57% of all households. Thus, the increasing prevalence of pet ownership is a key factor propelling the growth of the aminoglycosides market.
Aminoglycosides Market Segment Trends And Revenue Contributors
The aminoglycosides market covered in this report is segmented –
1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products
2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral
3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases
Aminoglycosides Market Industry Trends Fueling Future Revenue Growth
Companies operating in the aminoglycosides market are prioritizing the development of innovative solutions, such as improvements in advanced manufacturing and formulation processes, to meet the growing demand for highly effective, next-generation antibiotics capable of treating resistant bacterial infections. These process innovations lead to enhanced purity, stability, and therapeutic efficiency compared to traditional aminoglycoside production methods. For instance, in February 2024, Cipla Limited, an India-based pharmaceutical company, obtained approval from the Central Drugs Standard Control Organization (CDSCO) for ZEMDRI (plazomicin), an intravenous aminoglycoside antibiotic, in India. This antibiotic is specifically indicated for managing complicated urinary tract infections (cUTIs), including pyelonephritis.
Aminoglycosides Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience Limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc, Allergan PLC, Bristol Myers Squibb Company
View The Full Aminoglycosides Market Report:
Aminoglycosides Market Largest Region By Revenue And Market Share
Asia-Pacific was the largest region in the aminoglycosides market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
